Emerging Therapies for Alcohol-Associated Hepatitis
Promising medications, biologics, and interventions that address the pathophysiology of alcohol-associated hepatitis are in clinical trials, according to the authors of a review article. Liver
Promising medications, biologics, and interventions that address the pathophysiology of alcohol-associated hepatitis are in clinical trials, according to the authors of a review article. Liver
Adverse dental outcomes were significantly more common among 21,404 users of sublingual buprenorphine/naloxone than in those using transdermal buprenorphine (n = 5,385) and oral naltrexone
Fentanyl and psychostimulants were responsible for much of an 81% increase in fatal overdoses among pregnant and postpartum Americans in 2017–20, a study shows. “Although
Use of buprenorphine during pregnancy in people with opioid use disorder is safer for the baby than using methadone, a cohort study shows, but adverse
Oral naltrexone significantly improved drinking outcomes among sexual and gender minority men (SGM; men who have sex with men and transgender men) with mild-to-moderate alcohol
Management of opioid use disorder (OUD) should be transformed through universal treatment with medications such as methadone, buprenorphine, and naltrexone, conclude authors of a Perspective